Business (Details Narrative) - USD ($) |
1 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 02, 2021 |
Nov. 30, 2020 |
Nov. 18, 2020 |
Jan. 18, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
|
Cash and cash equivalents | $ 5,960,594 | $ 5,069,266 | ||||
Proceeds from issuance of common stock and warrants | $ 4,591,349 | |||||
Estimated gross proceeds from offering of shares | $ 502,717 | |||||
Common Stock [Member] | ||||||
Estimated gross proceeds from offering of shares | $ 3,689,761 | |||||
Reverse stock split | 1-for-6 reverse split | |||||
Phase 1b Clinical Trial [Member] | Minimum [Member] | ||||||
Estimated cost of clinical trial | $ 2,500,000 | |||||
Phase 1b Clinical Trial [Member] | Maximum [Member] | ||||||
Estimated cost of clinical trial | $ 2,900,000 |
X | ||||||||||
- Definition Estimated cost of clinical trial. No definition available.
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|